Target Name: FYTTD1
NCBI ID: G84248
Other Name(s): DKFZp761B1514 | Forty-two-three domain containing 1, transcript variant 1 | Protein 40-2-3 | UAP56-interacting factor | UIF_HUMAN | protein 40-2-3 | OTTHUMP00000208032 | FYTTD1 variant 1 | OTTHUMP00000208027 | OTTHUMP00000208031 | forty-two-three domain-containing protein 1 | UAP56-interacting factor (isoform 1) | Forty-two-three domain-containing protein 1 | forty-two-three domain containing 1 | OTTHUMP00000208028 | UIF

A closer look at FYTTD1 (DKFZp761B1514), a potential drug target and biomarker

Fungal infections are a common pathogen that affect millions of people worldwide, leading to various health conditions such as systemic fungal infections, athlete's foot, and nail fungus. In recent years, the discovery of new drug targets and biomarkers has provided new insights into the treatment of fungal infections. Among them, FYTTD1 (DKFZp761B1514) has shown great potential as a drug target and biomarker.

FTYTTD1: A novel protein involved in fungal interactions

FTYTTD1 is a protein that belongs to the Fungal Infection Research Group (FIRG) family, which is known for their role in the interactions between fungi and the host. The FIRG proteins function as negative regulators, preventing the growth and spread of fungi. FYTTD1, in particular, plays a crucial role in the regulation of the fungal-associated protein (F-AP) complex, which is involved in various fungal interactions.

The F-AP complex is a protein complex composed of various subunits, including FYTTD1, that work together to regulate the fungal response to various stimuli. FYTTD1 functions as a negative regulator, preventing the formation of the F-AP complex and thereby limiting the fungal response to stimuli.

FYTTD1 as a drug target

The discovery of FYTTD1 as a potential drug target has significant implications for the treatment of fungal infections. By inhibiting the activity of FYTTD1, drugs can effectively treat fungal infections and avoid the development of drug resistance.

One of the challenges in the treatment of fungal infections is the development of drug resistance, which can significantly reduce the effectiveness of existing treatments. FYTTD1 plays a crucial role in the development of drug resistance, as it helps to prevent the formation of the F-AP complex, which is involved in the production of drug resistance.

In addition, FYTTD1 has been shown to be involved in the regulation of various cellular processes, including cell adhesion, migration, and invasion. Therefore, inhibiting the activity of FYTTD1 may have implications for the treatment of various types of fungal infections, including athlete's foot, fungal infections of the scalp and face, and invasive fungal infections.

FYTTD1 as a biomarker

FYTTD1 has also been shown to be a potential biomarker for the diagnosis and monitoring of fungal infections. The F-AP complex, which is regulated by FYTTD1, is involved in the production of various biomarkers that can be used for the diagnosis of fungal infections.

For example, the production of extracellular matrix (ECM) components, such as hyaluronic acid and collagen, is regulated by the F-AP complex, and can be used as a biomarker for the diagnosis of fungal infections. Similarly, the production of pigment-producing enzymes, such as melanin, is also regulated by the F-AP complex, and can be used as a biomarker for the diagnosis of certain types of fungal infections.

In addition, the activity of FYTTD1 has been shown to be involved in the regulation of cellular stress responses, which can be used as a biomarker for the diagnosis and treatment of fungal infections that are associated with cellular stress.

Conclusion

In conclusion, FYTTD1 (DKFZp761B1514) has shown great potential as a drug target and biomarker for the treatment of fungal infections. The inhibition of FYTTD1 activity may have implications for the treatment of various types of fungal infections, including athlete's foot, fungal infections of the scalp and face, and invasive fungal infections. Further research is needed to fully understand the role of FYTTD1

Protein Name: Forty-two-three Domain Containing 1

Functions: Required for mRNA export from the nucleus to the cytoplasm. Acts as an adapter that uses the DDX39B/UAP56-NFX1 pathway to ensure efficient mRNA export and delivering to the nuclear pore. Associates with spliced and unspliced mRNAs simultaneously with ALYREF/THOC4

More Common Targets

FZD1 | FZD10 | FZD10-AS1 | FZD2 | FZD3 | FZD4 | FZD4-DT | FZD5 | FZD6 | FZD7 | FZD8 | FZD9 | FZR1 | G protein-Coupled Inwardly-Rectifying Potassium Channel (GIRK) | G Protein-Coupled Receptor Kinases (GRKs) | G0S2 | G2E3 | G2E3-AS1 | G3BP1 | G3BP2 | G6PC1 | G6PC2 | G6PC3 | G6PD | GA-binding protein | GAA | GAB1 | GAB2 | GAB3 | GAB4 | GABA(A) receptor | GABARAP | GABARAPL1 | GABARAPL2 | GABARAPL3 | GABBR1 | GABBR2 | GABPA | GABPAP | GABPB1 | GABPB1-AS1 | GABPB1-IT1 | GABPB2 | GABRA1 | GABRA2 | GABRA3 | GABRA4 | GABRA5 | GABRA6 | GABRB1 | GABRB2 | GABRB3 | GABRD | GABRE | GABRG1 | GABRG2 | GABRG3 | GABRG3-AS1 | GABRP | GABRQ | GABRR1 | GABRR2 | GABRR3 | GACAT1 | GACAT2 | GACAT3 | GAD1 | GAD2 | GADD45A | GADD45B | GADD45G | GADD45GIP1 | GADL1 | GAGE1 | GAGE10 | GAGE12B | GAGE12C | GAGE12D | GAGE12F | GAGE12G | GAGE12H | GAGE12J | GAGE2A | GAGE2B | GAGE2C | GAGE2D | GAGE4 | GAGE5 | GAGE6 | GAGE7 | GAGE8 | GAK | GAL | GAL3ST1 | GAL3ST2 | GAL3ST3 | GAL3ST4 | Galanin receptor | GALC | GALE